Back to home
MEDP logo

Is MEDP (Medpace Holdings, Inc.) Halal or Haram?

NASDAQ Global SelectHealthcareMedical - Diagnostics & Research$11.85B2026-04-27
MEDP is Halal4/4 screens passed

Medpace Holdings comfortably passes all AAOIFI Shariah screening criteria, making it a Halal investment option. The company operates with exceptionally low leverage, maintaining a debt-to-market cap ratio of just 2.1%, well below the 33% threshold. Furthermore, its interest income is non-existent at 0.00%, highlighting a remarkably clean balance sheet free from impermissible financial activities.

Price Chart (5D)

$457.91+2.03 (+0.45%)
2026-06-082026-06-01

MEDP — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-06-08454.25462.09450.06457.90187K+0.80%
2026-06-05453.53458.00442.95454.25191K+0.16%
2026-06-04454.24466.22454.14458.69221K+0.98%
2026-06-03445.40451.68434.38450.82240K+1.22%
2026-06-02445.35449.38438.04445.59299K+0.05%
2026-06-01446.43460.90444.41451.47251K+1.13%
2026-05-29446.72453.54441.92447.11289K+0.09%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for MEDP

Business Activity

Permissible

Medpace Holdings passes the business activity screen as its core operations in clinical research and drug development services for the pharmaceutical and biotechnology industries are entirely permissible under Islamic principles.

Debt / Market Cap

2.11%

Debt: $250.5MThreshold: ≤33%

Interest Income

0.00%

Interest: $0Threshold: ≤5%

Cash & Securities

4.20%

Cash: $497.0MThreshold: ≤33%

About Medpace Holdings, Inc. (MEDP)

Medpace Holdings, Inc. (MEDP) is a globally recognized clinical contract research organization (CRO) that accelerates the development of medical devices and drugs. The company provides comprehensive Phase I to Phase IV clinical trial services, supporting the biotechnology, pharmaceutical, and medical device industries across North America, Europe, and Asia.

For Muslim investors, Medpace represents a strong Halal investment opportunity within the healthcare sector. The stock successfully passes all four AAOIFI Shariah screens, meaning both its core business activities in medical research and its financial structures align with Islamic financial principles.

From an Islamic finance perspective, Medpace boasts an exceptionally clean balance sheet. The company carries negligible interest-bearing debt, with a debt-to-market cap ratio of just 2.1%, and generates absolutely zero interest income, ensuring investors are not exposed to riba-based earnings.

Since there is no significant scholarly debate regarding the permissibility of clinical research, investors can feel confident in this stock's compliance. However, Muslim shareholders should continue to monitor the company's cash reserves and future acquisitions to ensure its financial ratios remain within AAOIFI thresholds.

CEO

August James Troendle

Employees

5,900

IPO Date

2016-08-11

Headquarters

Cincinnati, OH, US

MEDP Key Financial Statistics

Revenue

$2.53B

Net Income

$451.1M

EPS (Diluted)

$15.28

Stock Price

414.88

Beta

1.39

52-Week Range

284.1-628.916

Total Debt

$250.5M

Total Equity

$459.1M

Current Ratio

0.74

MEDP Financial Health & Profitability

Profit Margins

Gross Margin30.1%
Operating Margin21.1%
Net Margin17.8%

Revenue Growth (YoY)

+20.0%

Prior year: $2.11B

Net Cash

$246.6M

Cash: $497.0M — Debt: $250.5M

Frequently Asked Questions About MEDP

Is MEDP (Medpace Holdings, Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, MEDP is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (2.11% vs ≤33% threshold), interest income ratio (0.00% vs ≤5% threshold), and cash & securities ratio (4.20% vs ≤33% threshold).
What does Medpace Holdings, Inc. do?
Medpace Holdings, Inc. (MEDP) is a globally recognized clinical contract research organization (CRO) that accelerates the development of medical devices and drugs. The company provides comprehensive Phase I to Phase IV clinical trial services, supporting the biotechnology, pharmaceutical, and medical device industries across North America, Europe, and Asia. For Muslim investors, Medpace represents a strong Halal investment opportunity within the healthcare sector. The stock successfully passes all four AAOIFI Shariah screens, meaning both its core business activities in medical research and its financial structures align with Islamic financial principles. From an Islamic finance perspective, Medpace boasts an exceptionally clean balance sheet. The company carries negligible interest-bearing debt, with a debt-to-market cap ratio of just 2.1%, and generates absolutely zero interest income, ensuring investors are not exposed to riba-based earnings. Since there is no significant scholarly debate regarding the permissibility of clinical research, investors can feel confident in this stock's compliance. However, Muslim shareholders should continue to monitor the company's cash reserves and future acquisitions to ensure its financial ratios remain within AAOIFI thresholds. Medpace Holdings, Inc. operates in the Healthcare sector under the Medical - Diagnostics & Research industry and is headquartered in Cincinnati, OH, US. The company is led by CEO August James Troendle and employs approximately 5,900 people.
What screening criteria were used for MEDP?
MEDP was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. MEDP passed 4 of these 4 screens.
Does MEDP require income purification?
MEDP has negligible interest income, so purification may not be necessary. However, it is always advisable to consult a qualified scholar regarding your specific investment situation.
When was MEDP last screened?
MEDP was last screened on 2026-04-27. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for MEDP (Medpace Holdings, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-27.

Other Halal Stocks in Healthcare